ITGAM and acute myeloid leukemia: Until now, many studies have demonstrated that CD11b positivity is associated with poor prognosis of AML patients[26,27], but still some other studies yielded conflicting results[28], which means that the prognostic value of CD11b for AML patients is controversial.